These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17015911)

  • 1. Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
    Rolleman EJ; de Jong M; Valkema R; Kwekkeboom D; Kam B; Krenning EP
    J Nucl Med; 2006 Oct; 47(10):1730-1; author reply 1731. PubMed ID: 17015911
    [No Abstract]   [Full Text] [Related]  

  • 2. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
    van Eerd JE; Vegt E; Wetzels JF; Russel FG; Masereeuw R; Corstens FH; Oyen WJ; Boerman OC
    J Nucl Med; 2006 Mar; 47(3):528-33. PubMed ID: 16513623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
    Vegt E; Wetzels JF; Russel FG; Masereeuw R; Boerman OC; van Eerd JE; Corstens FH; Oyen WJ
    J Nucl Med; 2006 Mar; 47(3):432-6. PubMed ID: 16513612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy.
    Moorin RE; Meyrick DP; Rose A
    Nucl Med Commun; 2007 Apr; 28(4):261-6. PubMed ID: 17325588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide.
    Verwijnen SM; Krenning EP; Valkema R; Huijmans JG; de Jong M
    J Nucl Med; 2005 Dec; 46(12):2057-60. PubMed ID: 16330570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
    Barone R; Walrand S; Konijnenberg M; Valkema R; Kvols LK; Krenning EP; Pauwels S; Jamar F
    Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protection of mice against x-radiation using sodium succinate].
    Ivnitskiĭ IuIu; Shturm R
    Radiobiologiia; 1990; 30(5):704-6. PubMed ID: 2251365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The search for chemical compounds with potential radioprotective effects (review)].
    Vladimirov VG; Kostiukovskiĭ IaL; Slavachevskaia NM; Parfenov AI
    Farmakol Toksikol; 1972; 35(6):747-52. PubMed ID: 4569456
    [No Abstract]   [Full Text] [Related]  

  • 9. MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.
    Pashankar FD; O'Dorisio MS; Menda Y
    J Nucl Med; 2005 Jan; 46 Suppl 1():55S-61S. PubMed ID: 15653652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of folcysteine against acute radiation sickness].
    Oeriu S; Herscovici H; Singer D; Gane P
    Arzneimittelforschung; 1967 Oct; 17(10):1336-7. PubMed ID: 5632891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Animal experiments and clinical results with oxyphenbutazone in irradiation of the mouth and jaw region].
    Grasser H; Müller-Fassbender H; Prechtel K; Werner T
    Med Monatsschr; 1972 Sep; 26(9):430-8. PubMed ID: 5082179
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.
    Vegt E; de Jong M; Wetzels JF; Masereeuw R; Melis M; Oyen WJ; Gotthardt M; Boerman OC
    J Nucl Med; 2010 Jul; 51(7):1049-58. PubMed ID: 20554737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuclear oncology with monoclonal antibodies and peptides].
    Hosono M
    Kaku Igaku; 1998 Oct; 35(8):681-7. PubMed ID: 9847509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of radiation damage by dibasic sulfur-containing acids of a phenol series].
    Kozhokaru AF; Alekseeva LV; Akoev IG
    Radiobiologiia; 1982; 22(4):545-8. PubMed ID: 7146346
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroendocrine tumors. Peptide receptor radionuclide therapy.
    Forrer F; Valkema R; Kwekkeboom DJ; de Jong M; Krenning EP
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):111-29. PubMed ID: 17382268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiradiation effectiveness of amino acid mixtures of various compositions].
    Lapteva TA; Bezkrovnaia LA
    Radiobiologiia; 1989; 29(3):359-62. PubMed ID: 2762526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
    Kwekkeboom DJ; Teunissen JJ; Kam BL; Valkema R; de Herder WW; Krenning EP
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):561-73; x. PubMed ID: 17548040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical radiation protection of ovarian follicles of mice by MPG (2-mercaptopropionylglycine).
    Kumar A; Uma Devi P
    J Nucl Med Allied Sci; 1983; 27(1):9-12. PubMed ID: 6864327
    [No Abstract]   [Full Text] [Related]  

  • 19. In-111 pentatreotide uptake in a chondrosarcoma.
    Baxter KG; Rosenthal HG; Redick ML; Preston D
    Clin Nucl Med; 1996 Dec; 21(12):1008-9. PubMed ID: 8957636
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiation-protective properties of indolyl alkylaminoethanols].
    Vasin MV; Antipov VV; Suvorov NN; Preobrazhenskaia MN; Orlova LM
    Radiobiologiia; 1971; 11(5):779-81. PubMed ID: 5170038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.